journal
https://read.qxmd.com/read/38641794/healthcare-utilisation-and-economic-burden-of-migraines-among-bank-employees-in-china-a-probabilistic-modelling-study
#1
JOURNAL ARTICLE
Du Wei, Li Ping Wong, Xun He, Tharani Loganathan
BACKGROUND: Despite the recognised high prevalence of migraines among bank employees, yet their healthcare utilisation patterns and the economic burden of migraines remain underexplored. AIM: To examine migraine-related healthcare utilisation among bank employees in China, and to estimate the economic burden of migraines. METHODS: A cross-sectional survey was conducted in Guizhou province, China between May and October 2022. The HARDSHIP questionnaire was used to identify migraine-positive individuals and enquire about their healthcare utilisation and productivity losses...
April 19, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38637754/an-economic-evaluation-of-eptinezumab-for-the-preventive-treatment-of-migraine-in-the-uk-with-consideration-for-natural-history-and-work-productivity
#2
JOURNAL ARTICLE
Edward Griffin, Gawain Shirley, Xin Ying Lee, Susanne F Awad, Alok Tyagi, Peter J Goadsby
BACKGROUND: Migraine is a highly prevalent neurological disease with a substantial societal burden due to lost productivity. From a societal perspective, we assessed the cost-effectiveness of eptinezumab for the preventive treatment of migraine. METHODS: An individual patient simulation of discrete competing events was developed to evaluate eptinezumab cost-effectiveness compared to best supportive care for adults in the United Kingdom with ≥ 4 migraine days per month and prior failure of ≥ 3 preventive migraine treatments...
April 18, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38637736/dynamic-fluctuations-of-salivary-cgrp-levels-during-migraine-attacks-association-with-clinical-variables-and-phenotypic-characterization
#3
JOURNAL ARTICLE
Alicia Alpuente, Victor J Gallardo, Laila Asskour, Edoardo Caronna, Marta Torres-Ferrus, Patricia Pozo-Rosich
BACKGROUND: Migraine is a complex neurological disorder with significant heterogeneity in its clinical presentation and molecular mechanisms. Calcitonin gene-related peptide (CGRP) has emerged as a key player in migraine pathophysiology, but challenges remain in its utilization as a biomarker. This study aimed to investigate salivary CGRP levels during migraine attacks across the frequency spectrum and explore associations with clinical variables. METHODS: A prospective longitudinal pilot study was conducted, recruiting migraine patients from an outpatient headache clinic...
April 18, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38627631/effects-of-pde-3-inhibition-in-persistent-post-traumatic-headache-evidence-of-camp-dependent-signaling
#4
RANDOMIZED CONTROLLED TRIAL
Haidar M Al-Khazali, Rune H Christensen, Basit Ali Chaudhry, Anna G Melchior, Messoud Ashina, Rami Burstein, Håkan Ashina
BACKGROUND: Phosphodiesterase 3 (PDE-3) inhibition have been implicated in the neurobiologic underpinnings of migraine. Considering the clinical similarities between migraine and persistent post-traumatic headache (PPTH), we aimed to ascertain whether PDE-3 inhibition can elicit migraine-like headache in persons with PPTH. METHODS: We tested cilostazol, which inhibits PDE-3, in a randomized, double-blind, placebo-controlled, two-way crossover study involving persons with PPTH attributed to mild traumatic brain injury...
April 17, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38627638/rimegepant-orally-disintegrating-tablet-75%C3%A2-mg-for-acute-treatment-of-migraine-in-adults-from-china-a-subgroup-analysis-of-a-double-blind-randomized-placebo-controlled-phase-3-clinical-trial
#5
RANDOMIZED CONTROLLED TRIAL
Shengyuan Yu, Aihong Guo, Zhen Wang, Jianguang Liu, Ge Tan, Qian Yang, Mingjie Zhang, Hasiyeti Yibulaiyin, Huisheng Chen, Yongbo Zhang, Robert Croop, Yanhui Sun, Yu Liu, Qian Zhao, Zhihong Lu
BACKGROUND: Rimegepant orally disintegrating tablet (ODT), an oral small-molecule calcitonin gene-related peptide receptor antagonist, is indicated for acute and preventive treatment of migraine in the United States and other countries. Previously, a large clinical trial assessed the efficacy and safety of rimegepant ODT 75 mg for the acute treatment of migraine in adults living in China or South Korea. A post hoc subgroup analysis of this trial was performed to evaluate the efficacy and safety of rimegepant for acute treatment of migraine in adults living in China...
April 16, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38609895/photophobia-is-associated-with-lower-sleep-quality-in-individuals-with-migraine-results-from-the-american-registry-for-migraine-research-armr
#6
JOURNAL ARTICLE
Nina Sharp, Mark J Burish, Kathleen B Digre, Jessica Ailani, Mahya Fani, Sophia Lamp, Todd J Schwedt
BACKGROUND: Patients with migraine often have poor sleep quality between and during migraine attacks. Furthermore, extensive research has identified photophobia as the most common and most bothersome symptom in individuals with migraine, second only to headache. Seeking the comfort of darkness is a common strategy for managing pain during an attack and preventing its recurrence between episodes. Given the well-established effects of daily light exposure on circadian activity rhythms and sleep quality, this study aimed to investigate the relationship between photophobia symptoms and sleep quality in a cohort of patients with migraine...
April 12, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38600467/reconceptualizing-autonomic-function-testing-in-migraine-a-systematic-review-and-meta-analysis
#7
REVIEW
Antun R Pavelić, Karin Zebenholzer, Christian Wöber
BACKGROUND: Autonomic nervous system (ANS) testing has aided in our ability to evaluate autonomic dysfunction in migraine patients. We reviewed the literature in multiple databases which investigate ANS function in migraine patients and healthy subjects. METHODS: This systematic review and meta-analysis examined the respective deep breathing, Valsalva manoeuvre, orthostatic and isometric challenge results, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analyses of Observational Studies in Epidemiology (MOOSE) statements...
April 10, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38584260/alterations-of-the-alpha-rhythm-in-visual-snow-syndrome-a-case-control-study
#8
JOURNAL ARTICLE
Antonia Klein, Sarah A Aeschlimann, Frederic Zubler, Adrian Scutelnic, Franz Riederer, Matthias Ertl, Christoph J Schankin
BACKGROUND: Visual snow syndrome is a disorder characterized by the combination of typical perceptual disturbances. The clinical picture suggests an impairment of visual filtering mechanisms and might involve primary and secondary visual brain areas, as well as higher-order attentional networks. On the level of cortical oscillations, the alpha rhythm is a prominent EEG pattern that is involved in the prioritisation of visual information. It can be regarded as a correlate of inhibitory modulation within the visual network...
April 8, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38580904/the-prevalence-and-demographic-associations-of-headache-in-the-adult-population-of-benin-a-cross-sectional-population-based-study
#9
JOURNAL ARTICLE
Thierry Adoukonou, Mendinatou Agbetou, Eric Dettin, Oyene Kossi, Andreas Husøy, Hallie Thomas, Dismand Houinato, Timothy J Steiner
BACKGROUND: The Global Burden of Disease (GBD) study is increasingly well informed with regard to headache disorders, but sub-Saharan Africa (SSA) remains one of the large regions of the world with limited data directly derived from population-based studies. The Global Campaign against Headache has conducted three studies in this region: Ethiopia in the east, Zambia in the south and Cameroon in Central SSA. Here we report a similar study in Benin, the first from West SSA. METHODS: We used the same methods and questionnaire, applying cluster-randomized sampling in three regions of the country, randomly selecting households in each region, visiting these unannounced and randomly selecting one adult member (aged 18-65 years) of each household...
April 5, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38575868/cgrp-targeted-medication-in-chronic-migraine-systematic-review
#10
REVIEW
Renato Oliveira, Raquel Gil-Gouveia, Francesca Puledda
BACKGROUND: Chronic migraine is a highly debilitating condition that is often difficult to manage, particularly in the presence of medication overuse headache. Drugs targeting the calcitonin gene-related peptide (CGRP), or its receptor have shown promising results in treating this disorder. METHODS: We searched Pubmed and Embase to identify randomized clinical trials and real-world studies reporting on the use of medication targeting the calcitonin gene-related peptide in patients with chronic migraine...
April 5, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38566009/the-prevalence-and-demographic-associations-of-headache-in-the-adult-population-of-peru-a-national-cross-sectional-population-based-study
#11
JOURNAL ARTICLE
Guiovanna Quispe, Cesar Loza, Luis Limaco, Ruth Gallegos, Carlos Palomino, Ivett Cruz, Jacqueline Miranda, Liliana Rodriguez, Andreas Husøy, Timothy J Steiner
BACKGROUND: The Global Campaign against Headache is conducting a series of population-based studies to fill the large geographical gaps in knowledge of headache prevalence and attributable burden. One major region not until now included is South America. Here we present a study from Peru, a country of 32.4 million inhabitants located at the west coast of South America, notable for its high Andes mountains. METHODS: The study was conducted in accordance with the standardized methodology used by the Global Campaign...
April 3, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38565983/the-prevalence-of-headache-in-the-adult-population-of-morocco-a-cross-sectional-population-based-study
#12
JOURNAL ARTICLE
Najib Kissani, Latifa Adarmouch, Aboubacar Sidik Sidibe, Abderrahmane Garmane, Rachid Founoun, Mohamed Chraa, Hallie Thomas, Andreas Husøy, Timothy J Steiner
BACKGROUND: The series of population-based studies conducted by the Global Campaign against Headache has, so far, included Pakistan and Saudi Arabia from the Eastern Mediterranean Region. The Maghreb countries of North Africa, also part of this Region, are geographically apart and culturally very different from these countries. Here we report a study in Morocco. METHODS: We applied the standardised methodology of Global Campaign studies, with cluster-randomized sampling in regions of Morocco selected to be representative of its diversities...
April 3, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38565987/unveiling-the-therapeutic-potential-of-dl-3-n-butylphthalide-in-ntg-induced-migraine-mouse-activating-the-nrf2-pathway-to-alleviate-oxidative-stress-and-neuroinflammation
#13
JOURNAL ARTICLE
Yingyuan Liu, Zihua Gong, Deqi Zhai, Chunxiao Yang, Guangshuang Lu, Shuqing Wang, Shaobo Xiao, Chenhao Li, Ludan Chen, Xiaoxue Lin, Shuhua Zhang, Shengyuan Yu, Zhao Dong
BACKGROUND: Migraine stands as a prevalent primary headache disorder, with prior research highlighting the significant involvement of oxidative stress and inflammatory pathways in its pathogenesis and chronicity. Existing evidence indicates the capacity of Dl-3-n-butylphthalide (NBP) to mitigate oxidative stress and inflammation, thereby conferring neuroprotective benefits in many central nervous system diseases. However, the specific therapeutic implications of NBP in the context of migraine remain to be elucidated...
April 2, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38561692/increased-cx3cl1-in-cerebrospinal-fluid-and-ictal-serum-t-tau-elevations-in-migraine-results-from-a-cross-sectional-exploratory-case-control-study
#14
JOURNAL ARTICLE
Marie Süße, Christine Kloetzer, Sebastian Strauß, Johanna Ruhnau, Lucas Hendrik Overeem, Merle Bendig, Juliane Schulze, Uwe Reuter, Antje Vogelgesang, Robert Fleischmann
BACKGROUND: To date, migraine is diagnosed exclusively based on clinical criteria, but fluid biomarkers are desirable to gain insight into pathophysiological processes and inform clinical management. We investigated the state-dependent profile of fluid biomarkers for neuroaxonal damage and microglial activation as two potentially relevant aspects in human migraine pathophysiology. METHODS: This exploratory study included serum and cerebrospinal fluid (CSF) samples of patients with migraine during the headache phase (ictally) (n = 23), between attacks (interictally) (n = 16), and age/sex-matched controls (n = 19)...
April 2, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38561646/the-burden-attributable-to-primary-headache-disorders-in-children-and-adolescents-in-ethiopia-estimates-from-a-national-schools-based-study
#15
JOURNAL ARTICLE
Yared Zenebe Zewde, Mehila Zebenigus, Hanna Demissie, Redda Tekle-Haimanot, Derya Uluduz, Tayyar Şaşmaz, Fatma Bozdag, Timothy J Steiner
BACKGROUND: We previously reported high prevalences of headache disorders among children (6-11 years) and adolescents (12-17 years) in Ethiopia. Here we provide data on headache-attributed burden collected contemporaneously from the same study participants. Part of the global schools-based programme within the Global Campaign against Headache, the study is the first to present such data from sub-Saharan Africa. METHODS: A cross-sectional survey following the generic protocol for the global study was conducted in six schools (urban and rural), in Addis Ababa city and three regions of Ethiopia...
April 2, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38549121/structural-equation-modeling-for-identifying-the-drivers-of-health-related-quality-of-life-improvement-experienced-by-patients-with-migraine-receiving-eptinezumab
#16
JOURNAL ARTICLE
Linus Jönsson, Susanne F Awad, Stephane A Regnier, Brian Talon, Steven Kymes, Xin Ying Lee, Peter J Goadsby
BACKGROUND: As new migraine therapies emerge, it is crucial for measures to capture the complexities of health-related quality of life (HRQoL) improvement beyond improvements in monthly migraine day (MMD) reduction. Investigations into the correlations between MMD reduction, symptom management, and HRQoL are lacking, particularly those that focus on improvements in canonical symptoms and improvement in patient-identified most-bothersome symptoms (PI-MBS), in patients treated with eptinezumab...
March 28, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38528477/frequency-and-predictors-of-headache-in-the-first-12-months-after-traumatic-brain-injury-results-from-center-tbi
#17
JOURNAL ARTICLE
Emilie Isager Howe, Nada Andelic, Cathrine Brunborg, Marina Zeldovich, Eirik Helseth, Toril Skandsen, Alexander Olsen, Silje C R Fure, Alice Theadom, Katrin Rauen, Benedikte Å Madsen, Bram Jacobs, Joukje van der Naalt, Maria Carmela Tartaglia, Cathrine Elisabeth Einarsen, Gøril Storvig, Erling Tronvik, Cathrine Tverdal, Nicole von Steinbüchel, Cecilie Røe, Torgeir Hellstrøm
BACKGROUND: Headache is a prevalent and debilitating symptom following traumatic brain injury (TBI). Large-scale, prospective cohort studies are needed to establish long-term headache prevalence and associated factors after TBI. This study aimed to assess the frequency and severity of headache after TBI and determine whether sociodemographic factors, injury severity characteristics, and pre- and post-injury comorbidities predicted changes in headache frequency and severity during the first 12 months after injury...
March 25, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38528476/long-term-treatment-with-lasmiditan-in-patients-with-migraine-post-hoc-analysis-of-treatment-patterns-and-outcomes-from-the-open-label-extension-of-the-centurion-randomized-trial
#18
RANDOMIZED CONTROLLED TRIAL
Mika Komori, Akichika Ozeki, Yuka Tanji, Eriko Kamiki, John H Krege, Lily Qian Li, Shiho Suzuki, Mamoru Shibata, Takao Takeshima
BACKGROUND: The objective of this analysis was to gain new insights into the patient characteristics and other factors associated with lasmiditan usage and clinical outcomes under conditions resembling the real-world setting. METHODS: This was a post hoc analysis of data from the 12-month, open-label extension (OLE) of the phase 3, double-blind, randomized, controlled CENTURION trial, which examined the efficacy and safety of lasmiditan as acute treatment across four migraine attacks...
March 25, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38515027/headache-in-the-adult-population-of-cameroon-prevalence-estimates-and-demographic-associations-from-a-cross-sectional-nationwide-population-based-study
#19
JOURNAL ARTICLE
Callixte Kuate Tegueu, Anastase Dzudie Tamdja, Franklin Kom, Blaise Forgwa Barche, Peter Ebasone, Mélanie Magnerou, Paul Mbonda, Jacques Doumbe, Andreas Husøy, Hallie Thomas, Timothy J Steiner
BACKGROUND: Knowledge of headache prevalence, and the burdens attributable to headache disorders, remains incomplete in sub-Saharan Africa (SSA): reliable studies have been conducted only in Zambia (southern SSA) and Ethiopia (eastern SSA). As part of the Global Campaign against Headache, we investigated the prevalence of headache in Cameroon, in Central SSA. METHODS: We used the same methodology as the studies in Zambia and Ethiopia, employing cluster-randomized sampling in four regions of Cameroon, selected to reflect the country's geographic, ethnic and cultural diversities...
March 21, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38504182/the-burden-of-headache-disorders-in-north-india-methodology-and-validation-of-a-hindi-version-of-the-hardship-questionnaire-for-a-community-based-survey-in-delhi-and-national-capital-territory-region
#20
JOURNAL ARTICLE
Ashish Duggal, Debashish Chowdhury, Anand Krishnan, Ritvik Amarchand, Timothy J Steiner
BACKGROUND: Knowledge of the prevalence and attributable burden of headache disorders in India is sparse, with only two recent population-based studies from South and East India. These produced conflicting results. A study in North India is needed. We report the methodology of such a study using, and validating, a Hindi translation of the Headache-Attributed Restriction, Disability, Social Handicap, and Impaired Participation (HARDSHIP) questionnaire developed by Lifting The Burden (LTB)...
March 19, 2024: Journal of Headache and Pain
journal
journal
34963
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.